AU5325696A - Method of modulating gene expression without depleting compl ement - Google Patents
Method of modulating gene expression without depleting compl ementInfo
- Publication number
- AU5325696A AU5325696A AU53256/96A AU5325696A AU5325696A AU 5325696 A AU5325696 A AU 5325696A AU 53256/96 A AU53256/96 A AU 53256/96A AU 5325696 A AU5325696 A AU 5325696A AU 5325696 A AU5325696 A AU 5325696A
- Authority
- AU
- Australia
- Prior art keywords
- depleting
- gene expression
- modulating gene
- compl
- ement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000295 complement effect Effects 0.000 title 1
- 230000000779 depleting effect Effects 0.000 title 1
- 230000014509 gene expression Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41538195A | 1995-04-03 | 1995-04-03 | |
US415381 | 1995-04-03 | ||
PCT/US1996/004327 WO1996031600A1 (en) | 1995-04-03 | 1996-03-29 | Method of modulating gene expression without depleting complement |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5325696A true AU5325696A (en) | 1996-10-23 |
Family
ID=23645461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53256/96A Abandoned AU5325696A (en) | 1995-04-03 | 1996-03-29 | Method of modulating gene expression without depleting compl ement |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5325696A (en) |
WO (1) | WO1996031600A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6624293B1 (en) | 1995-08-17 | 2003-09-23 | Hybridon, Inc. | Modified protein kinase A-specific oligonucleotides and methods of their use |
US7074768B2 (en) | 1995-08-17 | 2006-07-11 | Idera Pharmaceuticals, Inc. | Modified protein kinase A-specific oligonucleotides and methods of their use |
US5969117A (en) * | 1995-08-17 | 1999-10-19 | Hybridon, Inc. | Modified protein kinase a-specific oligonucleotide |
EP0856579A1 (en) | 1997-01-31 | 1998-08-05 | BIOGNOSTIK GESELLSCHAFT FÜR BIOMOLEKULARE DIAGNOSTIK mbH | An antisense oligonucleotide preparation method |
JP2002501370A (en) * | 1997-03-12 | 2002-01-15 | ハイブライドン,インク. | Improved protein kinase A characteristic oligonucleotides and methods of using the same |
CA2366408A1 (en) * | 1999-05-03 | 2000-11-30 | Methylgene, Inc. | Inhibition of histone deacetylase |
US9758786B2 (en) | 2016-02-09 | 2017-09-12 | Autotelic, Llc | Compositions and methods for treating pancreatic cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5652355A (en) * | 1992-07-23 | 1997-07-29 | Worcester Foundation For Experimental Biology | Hybrid oligonucleotide phosphorothioates |
EP0693123A1 (en) * | 1993-03-31 | 1996-01-24 | HYBRIDON, Inc. | Modified oligonucleotides having improved anti-influenza activity |
JPH09506248A (en) * | 1993-11-16 | 1997-06-24 | ジンタ・インコーポレイテッド | Chimeric oligonucleoside compound |
-
1996
- 1996-03-29 WO PCT/US1996/004327 patent/WO1996031600A1/en active Application Filing
- 1996-03-29 AU AU53256/96A patent/AU5325696A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996031600A1 (en) | 1996-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6614696A (en) | Inhibition of gene expression | |
AU6883798A (en) | Method of anesthesia | |
AU5262996A (en) | Telecommunications reward method | |
AU6174696A (en) | Inhibitors of phospholipase a2 | |
AU5524896A (en) | Modulators of ob gene and screening methods therefor | |
AU6614596A (en) | Inhibition of gene expression | |
AU5299696A (en) | Methods of inhibiting cell-cell adhesion | |
AU1406497A (en) | Mutational variants of mammalian ob gene proteins | |
AU7073096A (en) | Inhibited biological degradation of oligodeoxynucleotides | |
AU5818196A (en) | Method of pest control | |
AU6010294A (en) | Modulators of gene expression | |
AU5175796A (en) | Method of identifying molecules that regulate fgf activity | |
AU4479096A (en) | 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 | |
AU6950096A (en) | Methods and compositions for nucleic acid targeting | |
AU5325696A (en) | Method of modulating gene expression without depleting compl ement | |
AU4397797A (en) | Method of gene introduction | |
AU6986496A (en) | Retinoylamide based derivatives of sphingoid bases | |
AU6469699A (en) | Method of regulating gene expression | |
EP0773262A3 (en) | Two-part curable liquid silicone composition | |
AU2548095A (en) | Human inhibitor of apoptosis gene 1 | |
AUPO947997A0 (en) | Method of regulating gene expression | |
AU7422498A (en) | Method for isolation of biosynthesis genes for bioactive molecules | |
AU7482696A (en) | Methods for administration of il-12 | |
AU6097896A (en) | Oral delivery of gene constructs | |
AU8816898A (en) | Method of drug selection |